VeriChip Corporation announced today that it will unveil details and plans to build a prototype self-contained implantable bio-sensing device included on a microchip that will have the ability to measure glucose levels.
If this prototype gets off the ground and actually functions properly, it will relieve millions of diabetes sufferers from having to having to prick themselves to be able to monitor their glucose levels. The device is expected to be able to monitor levels and transmit the data to an outside data receptor, possibly something as simple as a cell phone.
Commenting on the event, Scott R Silverman, Chairman and CEO of VeriChip Corporation stated “Upon complete development, this technology can change the lives of patients with diabetes, providing them with a convenient way to monitor their blood-sugar levels. Today, the common method involves a prick of the finger. Our self-contained sensor can change that and negate the need for daily invasive testing. This system will allow for one injection every 4-6 months (approximate) that permits the diabetic to externally scan the device and retrieve a blood sugar reading as often as necessary.”
The event will take place at the Grand Hyatt in New York City at 4:30 p.m. EST and will feature a presentation by Robert E. Carlson, Ph.D., President and Principal Investigator at RECEPTORS LLC. RECEPTORS has partnered with VeriChip and Digital Angel to develop an innovative self-contained glucose-sensing system.
Comment Preview